Open Access

Association of iodized salt with goiter prevalence in Chinese populations: a continuity analysis over time

Military Medical Research20174:8

DOI: 10.1186/s40779-017-0118-5

Received: 20 July 2016

Accepted: 8 March 2017

Published: 21 March 2017

Abstract

Background

Iodine deficiency disorders (IDD) refer to diseases that are caused by insufficient iodine intake, and the best strategy to prevent IDD is the addition of iodine to dietary salt. Because iodine deficiency is a common cause of goiter, the prevalence as effectively controlled after the implementation of universal salt iodization (USI) in China. However, there is substantial controversy as to whether the incidence of thyroid disorders is related to iodized salt intake. Therefore, we aimed to clarify whether the risk of goiter can be promoted by USI.

Methods

A longitudinal continuous study based on the national monitoring results of IDD in China was performed for 3 consecutive years. We recorded the following indicators of IDD from 31 provinces: goiter number, two degrees of goiter (the degree of goiter severity) and cretinism (three endemic diseases), iodized salt intake, median urinary iodine concentration (UIC), soil iodine content and coverage rates of iodized salt. One-way Analysis of Variance (ANOVA) and linear regression analyses examined the differences between the three groups and correlations, respectively. Data were collected from the Chinese national IDD surveillance data in 2011-2013, and the background values of Chinese soil elements were published in 1990.

Results

A reference male’s daily intake of maximum iodine was 378.9 μg, 379.2 μg and 366.9 μg in 2011, 2012, and 2013, respectively. No statistical association between daily iodized salt intake and the three endemic diseases was observed in 2011-2013 (P > 0.05). No association was observed between daily iodized salt intake and the UIC of children in 2011 (P > 0.05). Linear regression revealed no significant correlation between the soil iodine content and three endemic diseases. The present study indicated no difference in the daily iodized salt intake in each province during three years (F = 0.886, P = 0.647). The coverage rate of iodized salt remained above 98.7%, and goiter rates were stable in 2011-2013.

Conclusion

There was no significant association between iodized salt intake and the three endemic diseases, suggesting that the current nutrition level of iodized salt did not cause the high goiter prevalence.

Keywords

Iodine deficiency disorders (IDD) Iodized salt China

Background

Iodine is an essential trace element for the synthesis of thyroid hormones containing thyroxine and tri-iodothyronine [1, 2]. Iodine in the soil can also be absorbed into the human food chain through plants, which may affect the occurrence of endemic goiter [35]. Iodine deficiency and excess intake lead to iodine deficiency disorders (IDDs) and iodine excess disorders (IEDs), respectively [1, 2]. Several risk factors, such as tobacco smoking, genetic factors, gender, alcohol and age, are associated with an increased risk of IDD, but iodine deficiency is realized as an important risk factor [6, 7]. Approximately 30 countries worldwide suffer from iodine deficiency, and 10 countries exhibit excessive iodine intake [8]. Iodine deficiency has widespread implications, including endemic goiter, cretinism, miscarriage and abnormal brain development in children [9, 10]. Moreover, IED can lead to hyperthyroidism, autoimmune thyroid disease and thyroid cancer [11]. The best strategy to prevent IDD is salt iodization, which is the most effective, economical and convenient measure for iodine fortification that is used in most countries [12].

These serious situations could affect a child’s growth and lead to mental retardation and dysgnosia as well as reduce the survival rates of children. The primary clinical manifestation was cretinism [13]. The USI program of China was launched in 1995 to prevent IDD, and it had a significant effect [14]. The level of iodine nutrition of the entire nation significantly improved, and IDD as effectively controlled. An assessment from the Chinese Ministry of Health in 2000 announced that China had completely eliminated IDD.

However, the health hazard of iodine excess gradually received attention after the implementation of USI in 1995. The UIC of school-aged children simultaneously sharply increased and reached 330 μg/L in 1997 and 306 μg/L in 1999 [15, 16], which was beyond the recommended levels of 100.0 to 199.9 μg/L and more than adequate (200.0 to 299.9 μg/L) according to the World Health Organization (WHO) [17]. Endocrinologists reported that the prevalence of goiter exhibited an increasing trend that was closely related to the amount of commonly consumed iodized salt [1820]. Therefore, whether it was scientifically sound and essential to sustain the USI program throughout China was heavily debated [2124]. There have been many cross-sectional studies, but these analyses suffered a lack of continuity over time.

Methods

Study setting

We collected national IDD surveillance data from three recent years and the content of iodine in soil from surveillance data in 1990. One-way Analysis of Variance (ANOVA) and linear regression analyses were used to examine differences between the three groups and correlations, respectively. Coverage rates of iodized salt from 1995, 1997, 1999, 2002, 2005 and 2011 to 2013 were selected to assess national iodized salt consumption levels. Ethical approval was obtained from the ethical committee of the Third Military Medical University in China. Written informed consent was obtained from every participant prior to enrollment.

Diagnostic criteria for thyroid disease

Thyroid ultrasonography was performed using a 7.5 MHz transducer to diagnose goiter. Experienced radiologists from the local Centers for Disease Control and Prevention measured the thyroid volumes in the 31 provinces. The thyroid lobe volume was calculated by measuring the depth (d), width (w) and length (l) of each lobe by the following formula: V (ml)  =  0.479 × d × w × l (mm)/1000. The thyroid volume was recorded as the sum of both lobes. The normal volumes for adult males and females are less than 25.6 ml and 19.4 ml [25], respectively.

Data collection and sampling

We collected consecutive national statistics data from August 2012 to September 2014. A probability proportional-to-size (PPS) cluster sampling was applied in the national IDD surveillance data.

Cases of IDD collection and processing

We collected data on the prevention and treatment of IDD in Chinese provinces for three consecutive three years (2011, 2012 and 2013). Provincial level indexes of the 31 provinces were applied when individual provinces lacked data in the statistical yearbook. The total population of each province is the sum of the number of diseased counties. The number of goiter cases in three years (not including Shanghai, Guangdong and Qinghai) as well as two degrees of goiter cases (not including Tianjin, Shanghai, Jiangsu, Guangxi, Qinghai and Guangdong in 2011 and 2012; Tianjin, Shanghai, Guangdong, Guangxi, Hainan and Qinghai were not included in 2013) and cretinism cases in three years (not including Beijing, Tianjin, Shanghai, Jiangsu, Hainan, Tibet and Guangdong) were collected. The prevalence of three endemic diseases rates (shown in ‱) were calculated using the following formula: the number of prevalent cases divided by the total population of each province in the diseased counties.

The index related to IDD

We chose the actual number of annual sales of iodized salt and non-iodized salt in 2011, 2012 and 2013. The type of salt was defined as follows: non-iodized salt, salt iodine less than 5 mg/kg, qualified iodized salt, salt iodine 20-30 mg/kg, others, and unqualified iodized salt [26]. The ratio of the number of iodine salts to the total number of salts represented the coverage rate of iodized salt in 2011-2013 (1995, 1997, 1999, 2002 and 2005 were five times the coverage rate of iodized salt collected from summary analysis of monitoring data of IDD in the entire country) [15, 16, 2729]. The UIC (μg/L) in school-aged children who were 8 to 10 years of age was determined in 2011. We did not assess surveillance data of the UIC in 2012 and 2013 because they were not available. We collected surveillance data of the soil iodine content in 1990 because background values of soil iodine did not significantly change in China [30]. All data came from the China Statistical Yearbook of Health and Family Planning issued in 2012, 2013 and 2014, which was conducted by the Peking Union Medical College Publishing House. The China Background Value of Soil Element was published by the China Environmental Science Press in 1990.

Statistical analyses

We used Microsoft Office Excel 2007 software to establish the database and create a line chart to reflect the coverage rates of iodized salt in each province. Data processing and statistical analyses were performed using SPSS statistics version 18.0. One-way ANOVA compared the three years of actual sales of iodized salt to identify significant differences. Pairwise comparisons were not performed if the null hypothesis was accepted (P > 0.05). Correlations between the incidence of the three endemic diseases, daily iodized salt intake, the UIC (μg/L) of children and the content of iodine in soil were analyzed using regression analyses to confirm the quantitative relationship between two or more variables. The results analyzed the value of Sig. (significance), which was the significance coefficient of the regression relationship and the actual significance probability of the F value, named the value of P. All tests of significance were two-tailed, and P < 0.05 was considered significant.

Results

Data summary

Table 1 presents the general features of three consecutive years of data, including 2011, 2012 and 2013. The total population with disease in the county was reduced by 2304.1 ten thousand people from 2011 to 2013 and the cases of three endemic diseases continue to decline. Per capita daily intake of iodine ranged from 244.6 to 379.2 μg/d, which exceeds the recommended dietary allowance of iodine 150 μg/d according to the WHO/UNICEF/ICCIDD [31].
Table 1

The general features of three consecutive years of data

Item

2011

2012

2013

The total population with disease in the county (ten thousand people)

132,636.8

130,498.5

130,332.7

The number of goiter cases (‱a)

4,897,422 (36.923,6)

4,800,287 (36.784,2)

4,624,814 (35.484,7)

The number of two degree of goiter cases (‱a)

230,621 (1.738,79)

224,834 (1.722,9)

219,635 (1.685,2)

The number of cretinism cases (‱a)

107,219 (0.808,4)

101,820 (0.780,2)

92,219 (0.707,6)

UIC (μg/L) in school-aged children 8 to 10 years of age

226.5

Annual sales of iodized salt (tons)

6,115,769

6,024,514

5,820,098

The number of iodine salt copies

812,617

834,523

797,154

The number of non-iodized salt copies

10,283

9978

8546

Coverage rate of iodized salt (percent)

98.750,4

98.818,5

98.939,3

Per capita daily intake of iodized salt (g)

12.63

12.64

12.23

Per capita daily intake of iodine (μg)

252.6-378.9

252.8-379.2

244.6-366.9

a: Indicates 1/10000 (‱)

Correlation between daily iodized salt intake, three endemic diseases and the UIC of children

Table 2 shows the associations of iodized salt intake with the rate of goiter, two degrees of goiter and cretinism in 2011, 2012 and 2013. Moreover, we evaluated the correlation between iodized salt intake and UIC in school-aged children 8 to 10 years of age in 2011. The daily iodized salt intake was not associated with the three endemic diseases or UIC because there was no significant relationship between these data (P > 0.05).
Table 2

Correlations between the daily iodized salt intake, three endemic diseases and UIC of children

Dependent variable

B

Std. Error

Beta

t value

P value

2011

 The rate of goiter

-2.738

4.472

-0.119

-0.612

0.546

 The rate of two-degree goiter

0.145

0.477

0.063

0.303

0.764

 The rate of cretinism

0.114

0.193

0.125

0.590

0.561

 UIC (μg/L) in school-aged children 8 to 10 years of age

-0.955

3.301

-0.054

-0.289

0.774

2012

 The rate of goiter

-2.606

4.642

-0.109

-0.561

0.579

 The rate of two-degree goiter

-0.030

0.532

-0.012

-0.056

0.956

 The rate of cretinism

0.174

0.174

0.209

1.000

0.328

2013

 The rate of goiter

-4.372

4.106

-0.204

-1.065

0.297

 The rate of two-degree goiter

-0.058

0.529

-0.023

-0.109

0.914

 The rate of cretinism

0.059

0.190

0.067

0.313

0.757

Correlation between the content of iodine in soil and three endemic diseases

Table 3 shows the associations of the iodine content in soil with the goiter rate, two-degree goiter and cretinism in 2011, 2012 and 2013. Linear regression revealed no significant correlation between these data (P > 0.05).
Table 3

Correlations between the content of iodine in soil and three endemic diseases

Dependent variable

B

Std. Error

Beta

t value

P value

2011

 The rate of goiter

1.730

4.187

0.082

0.413

0.683

 The rate of two-degree goiter

-0.439

0.467

-0.196

-0.940

0.358

 The rate of cretinism

-0.194

0.159

-0.251

-1.215

0.237

2012

 The rate of goiter

1.846

4.150

0.089

0.445

0.660

 The rate of two-degree goiter

-0.432

0.477

-0.190

-0.906

0.375

 The rate of cretinism

-0.175

0.154

-0.235

-1.132

0.270

2013

 The rate of goiter

2.670

3.752

0.141

0.711

0.483

 The rate of two-degree goiter

-0.259

0.454

-0.118

-0.572

0.573

 The rate of cretinism

-0.164

0.151

-0.226

-1.088

0.288

Changes in the daily iodized intake and coverage rate of iodized salt

Table 4 shows that one-way ANOVA revealed no differences in the daily iodized salt intake across the provinces in the three years (F = 0.886, P = 0.647). Figure 1 shows that the coverage rate of iodized salt exhibited large fluctuations in China. Since the implementation of USI in 1995, the coverage rate of iodized salt was increasing in successive years and exceeded 90% after 1997. From 2011 to 2013, the coverage rate of iodized salt stayed over 98.75%.
Table 4

Changes in the daily iodized salt intake

Year

Mean

Std. Deviation

Std. Error

P value

F value

2011 (n = 31)

12.8236

2.20918

0.39678

0.002

2012 (n = 31)

12.8477

2.19188

0.39367

0.003

2013 (n = 30a)

12.0787

2.02006

0.36881

0.176

Test of homogeneity of variances

0.692

0.370

ANOVA

0.647

0.886

a: There are 30 provinces because Shanghai provided no monitoring data in 2013

Fig. 1

Changes in the coverage rate of iodized salt. The line graph describes the results of 5 cross-sectional and 3 consecutive studies in chronological order

Goiter rates change in the three years

Table 5 shows that goiter rates were stable across the three years, and a decreasing trend was observed. Tibet exhibited a significant reduction in 2013 compared to the previous two years (2011 = 189.58‱, 2012 = 182.70‱, and 2013 = 132.79‱).
Table 5

Changes in goiter rates over three years

Region

The rate of goiter (‱a) in 2011

The rate of goiter (‱a) in 2012

The rate of goiter (‱a) in 2013

Total

36.92

36.78

35.48

Beijing

0.14

0.14

0.14

Tianjin

6.55

5.17

5.15

Hebei

12.26

11.50

11.50

Shanxi

11.64

11.40

10.56

Nei Monggol

61.33

55.42

55.40

Liaoning

30.26

30.35

29.72

Jilin

156.19

161.77

161.03

Heilongjiang

68.75

65.51

59.58

Shanghai

Jiangsu

46.07

42.99

33.84

Zhejiang

1.11

1.25

1.41

Anhui

14.97

14.97

4.06

Fujian

24.17

22.85

22.64

Jiangxi

89.72

90.65

89.74

Shandong

20.39

20.93

20.93

Henan

7.21

6.83

6.63

Hubei

24.97

29.64

29.21

Hunan

111.68

111.30

112.25

Guangdong

Guangxi

79.96

80.03

79.40

Hainan

7.22

2.37

0.43

Chongqing

41.74

39.89

42.43

Sichuan

12.01

11.91

11.91

Guizhou

83.95

81.02

80.81

Yunnan

3.84

3.56

3.44

Tibet

189.58

182.70

132.79

Shaanxi

105.44

104.25

103.32

Gansu

39.14

36.73

36.50

Qinghai

Ningxia

0.37

0.38

0.37

Xinjiang

23.38

22.48

22.23

a: Represent 1/10000 (‱) and data were not collected in Shanghai, Guangdong and Qinghai

Discussion

The present study used national epidemiological survey data because the monitoring system of IDD in China is relatively precise for monitoring the iodized salt intake by county and monitoring the prevalence of IDD by province, which provided strong support for the 2011-2013 national monitoring data. Our work is different from studies with many on-site surveys; instead, it stands on the overall continuous levels to explore the influence of USI on the IDD and assess the status of table salt as the carrier for iodine fortification, which has crucial significance. This study is also a consecutive analysis in time, which is rarely analyzed in the substantial cross-sectional study literature. Goiter prevalence, UIC and salt iodine are 3 indicators that exhibit their own characteristics within certain time limits of each other. Consequently, the results of a cross-sectional survey reflect only the status of iodine nutrition and prevalence in individuals at that time. It has been well documented in previous studies that the prevalence of goiter is an index that changes relatively slowly and steadily [32, 33]. Several years or longer are needed to achieve a non-epidemic state in an endemic region of goiter caused by iodine deficiency after the implementation of full supplement conditions [32]. In contrast, iodized salt with UIC produces rapid changes that allow the iodine levels of the population to be instantly measured. Therefore, studies of the fluctuation and changes in the IDD prevalence and the correlations between IDD with iodized salt and UIC may induce errors based on the reliance of cross-sectional results. A longitudinal continuous observation of the results of 3 consecutive monitoring periods may identify changing trends and laws as well as the occurrence of the problem.

Our findings of the continued reduction of IDD in China are consistent with previous studies [14, 34]. There was no significant association between iodized salt intake and the three endemic diseases, which revealed that the current nutrition level of iodized salt did not cause the high goiter prevalence. Even when considering the confounders of goiter, such as genetic, metabolism, drugs, etc., the most important factor remains the lack of iodine. Therefore, in accordance with these results, the controversy that iodized salt increased the risk of thyroid disorders in China in the past decade is beginning to be cleared. We demonstrated no differences in the daily iodized salt intake across the provinces in three years using one-way ANOVA, which suggests that the daily iodized salt intake levels of residents in the three consecutive years remained stable. The results of our data demonstrated that the daily iodine salt intake values of a reference male were 12.63 g, 12.64 g and 12.23 g in 2011, 2012 and 2013, respectively. The current standard for salt iodization in China is 20-30 mg/kg according to the fourth adjustment of the iodine content of edible salt in 2010 [26]. Taking 2012 as an example, the daily iodine intake of a reference male ranged from 252.8 to 379.2 μg. The recommended dietary allowance of iodine for an adult male is 150 μg/d according to the WHO/UNICEF/ICCIDD [31], and the tolerable daily intake (TDI) of iodine is 600 μg/d according to the WHO [35]. These criteria indicate that the current iodine intake in China exceeded the recommended nutrient intake of WHO, but it was below the TDI, which may explain the present results that iodized salt intake was not associated with the three endemic diseases in question. However, this finding indicates that we still need to reduce the intake of iodized salt or the iodine content of iodized salt to achieve a more conducive level of iodine intake for the health of residents in China.

The UIC is currently the most practical biochemical marker for iodine nutrition [36]. Our results indicated that the present iodized salt intake may not be associated with UIC in Chinese children. We analyzed the fundamental reasons for this result and concluded that the per capita daily intake of iodized salt may not exactly reflect the iodine intake in children, and the UIC varied considerably in different regions, studies, and research methods. Urinary iodine excretion, as determined by the iodine/creatinine ratio, is influenced by iodized salt intake and additional factors, such as the muscle mass and physical activity [37, 38]. The examination of only one year of UIC may not precisely evaluate the iodine nutrition of subjects. Therefore, accurate correlations of iodized salt with UIC in school-aged children deserve more thorough investigation with large sample studies. Our findings indicated that the UIC of school children aged 8–10 years was 226.5 μg/L in 2011. This iodine nutrition is adequate according to the 2007 criteria of the WHO/UNICEF/ICCIDD for assessing iodine nutrition [17]. These results demonstrate that iodized salt intake did not affect the UIC in children or exceed the appropriate level of iodine nutrition in children.

Different environments have differences in the iodine intake. Iodine in the soil is absorbed into the human food chain through plants, which could affect the intake of iodine and occurrence of goiter. However, we did not observe a significant association between the iodine soil content and the three endemic diseases. Iodine in the soil may exert a small effect on iodine intake in China, but iodized salt is the main source of iodine in the Chinese population [39].

We demonstrated that the coverage rate of iodized salt increased annually to over 98.7% in 2011-2013 (Fig. 1). This result suggests that the government’s prevention and cure of IDD is improving, and the coverage rates gradually stabilized in 2011. Iodized salt has become the primary source of dietary iodine.

Unlike the coverage rate of iodized salt, we observed that goiter prevalence decreased continuously, while it remained stable for three years (Table 5). This result illustrates that the current nutrition level of iodized salt did not cause the high goiter prevalence and iodine fortification-induced goiter is not extensive. Our previous studies focused more on the rise in thyroid disorders, such as goiter, hyperthyroidism, hypothyroidism, thyroiditis and other autoimmune disorders, which increased significantly after the implementation of USI in 1995 [40]. However, there are numerous predisposing factors for autoimmune thyroid disease, including genetic susceptibility and environmental factors, which commonly affect the incidence of this disease, and no studies have reported that iodized salt increased the high-iodine goiter prevalence worldwide in the nearly 90-year history of iodized salt. The government also adjusted the iodine concentration in iodized salt four times to maintain iodine nutrition at an appropriate level. Therefore, the Chinese government should adhere to the policies of the USI [41] because iodized salt reduces goiter prevalence [14].

There are some limitations to the present study. First, we lost the data from individual provinces, and only one year of UIC data is available, which may have biased the comprehensive analysis. Second, our survey data included only three years, which may be too short to observe changes in goiter prevalence. Additionally, there were no monitoring results for thyroid carcinoma and hyperthyroidism, which were deemed too closely related to the USI in many studies. It was more accurate to collect data from each city for linear regression.

Conclusions

The iodized salt may not increase the risk of the three endemic diseases at present. No statistical associations between iodized salt and the prevalence rates of goiter, two-degree goiter and cretinism were observed in Chinese populations. There were no significant relationships between the iodine soil content and the three endemic diseases in question. Non-iodized salt should be forbidden to improve the coverage rate of iodized salt, and this policy should be adopted to ensure that the UIC is maintained at an optimal level (100-199 μg/L). Future studies should monitor the local consumption rates of iodized salt to provide a more complete national database of iodine intake status. Our findings suggest that the USI policy should be enforced in China.

Abbreviations

ANOVA: 

Analysis of variance

IDD: 

Iodine deficiency disorders

IED: 

Iodine excess disorders

PPS: 

Probability proportional-to-size

TDI: 

Tolerable daily intake

UIC: 

Urinary iodine concentration

USI: 

Universal salt iodization

WHO: 

World Health Organization

Declarations

Acknowledgments

Not applicable.

Funding

This work was supported by the National Natural Science Foundation of China (No. 81372125).

Availability of data and materials

All relevant data and materials are presented in the paper.

Authors’ contributions

ZL, CX collected the data and completed the manuscript. YJL reviewed results and provided guidelines for presentation and interpretation. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Consent for publication has been obtained.

Ethics approval and consent to participate

This study was approved by the ethical committee of the Third Military Medical University in China.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Military Medical Geography, College of High Altitude Military Medicine, Third Military Medical University
(2)
Battalion 5 of Cadet Brigade, Third Military Medical University
(3)
Key Laboratory of High Altitude Medicine (PLA), Third Military Medical University

References

  1. Ares S, Quero J, de Escobar GM. Iodine balance, iatrogenic excess, and thyroid dysfunction in premature newborns. Semin Perinatol. 2008;32(6):407–12.View ArticlePubMedGoogle Scholar
  2. Fuge R. Iodine deficiency: an ancient problem in a modern world. Ambio. 2007;36(1):70–2.View ArticlePubMedGoogle Scholar
  3. Lewis K. Iodine deficiency disorders still prevalent in China. CMAJ. 2009;181(8):E151–2.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Mehra A, Saikat SQ, Carter JE. Bioavailability of iodine in the UK-Peak District environment and its human bioaccessibility: an assessment of the causes of historical goitre in this area. Environ Monit Assess. 2014;186(2):987–99.View ArticlePubMedGoogle Scholar
  5. Weng HX, Weng JK, Yan AL, Hong CL, Yong WB, Qin YC. Increment of iodine content in vegetable plants by applying iodized fertilizer and the residual characteristics of iodine in soil. Biol Trace Elem Res. 2008;123(1-3):218–28.View ArticlePubMedGoogle Scholar
  6. Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012;142(4):744–50.View ArticlePubMedGoogle Scholar
  7. Du Y, Gao Y, Meng F, Liu S, Fan Z, Wu J, et al. Iodine deficiency and excess coexist in china and induce thyroid dysfunction and disease: a cross-sectional study. PLoS One. 2014;9(11):e111937.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Pearce EN, Andersson M, Zimmermann MB. Global iodine nutrition: Where do we stand in 2013? Thyroid. 2013;23(5):523–8.View ArticlePubMedGoogle Scholar
  9. Delange F, Dunn JT, Glinoer D. Some problems of endemic goiter in Czecho-Slovakia yesterday, today and tomorrow. New York: Plenum Press; 1993. p. 353-57.Google Scholar
  10. Delange F. The disorders induced by iodine deficiency. Thyroid. 1994;4(1):107–28.View ArticlePubMedGoogle Scholar
  11. Wu L, Yu JC, Kang WM, Ma ZQ. Iodine nutrition and thyroid diseases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013;35(4):363–8.PubMedGoogle Scholar
  12. Azizi F, Sheikholeslam R, Hedayati M, Mirmiran P, Malekafzali H, Kimiagar M, et al. Sustainable control of iodine deficiency in Iran: Beneficial results of the implementation of the mandatory law on salt iodization. J Endocrinol Invest. 2002;25(5):409–13.View ArticlePubMedGoogle Scholar
  13. Chen ZP, Hetzel BS. Cretinism revisited. Best Pract Res Clin Endocrinol Metab. 2010;24(1):39–50.View ArticlePubMedGoogle Scholar
  14. Zhao W, Han C, Shi X, et al. Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis. PLoS One. 2014;9(10):e109549.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Chen J, Li Z, Xu H, Hao Y, Zhang Z, Liu J, et al. China National Iodine Deficiency Disorders Surveillance 1997. Beijing: People’s Medical Publishing House; 2000. p. 27–9.Google Scholar
  16. Chen X, Li Z, Hao Y, Xu H, Liu S, Zhang Z, et al. China National Iodine Deficiency Disorders Surveillance 1999. Beijing: People’s Medical Publishing House; 2002. p. 39–41.Google Scholar
  17. World Health Organization, United Nations Children’s Fund, and International Council for the Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination: A guide for programme managers. Geneva: World Health Organization; 2007. p. 32–4.Google Scholar
  18. Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L, et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol (Oxf). 2005;62(6):713–20.View ArticleGoogle Scholar
  19. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol. 2000;143(4):485–91.View ArticlePubMedGoogle Scholar
  20. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf). 2000;53(4):479–85.View ArticleGoogle Scholar
  21. Li S, Zheng Q, Xu J, Gorstein J, Wang H, Dong H. Iodine excess or not: analysis on the necessity of reducing the iodine content in edible salt based on the national monitoring results. Asia Pac J Clin Nutr. 2011;20(4):501–6.PubMedGoogle Scholar
  22. Yan YQ, Chen ZP, Yang XM, Liu H, Zhang JX, Zhong W, et al. Attention to the hiding iodine deficiency in pregnant and lactating women after universal salt iodization: A multi-community study in China. J Endocrinol Invest. 2005;28(6):547–53.View ArticlePubMedGoogle Scholar
  23. Wang Y, Zhang Z, Ge P, Wang Y, Wang S. Iodine status and thyroid function of pregnant, lactating women and infants (0-1 yr) residing in areas with an effective Universal Salt Iodization program. Asia Pac J Clin Nutr. 2009;18(1):34–40.PubMedGoogle Scholar
  24. Huang Q, Jin R, Zou D. Study on the effects of increased iodized salt intake on the incidence of thyroid diseases[Article in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2001;22(6):455–8.PubMedGoogle Scholar
  25. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, et al. Effect of iodine intake on thyroid diseases in China. New Engl J Med. 2006;354(26):2783–93.View ArticlePubMedGoogle Scholar
  26. Ministry of Health. Announcement on food safety national standard “iodine content in edible salt; 2011 [cited 2012 Mar 15]. Available from: http://www.nhfpc.gov.cn/zwgkzt/zswdx/201306/371562ad47f1475ab949f30d53729de5.shtml.
  27. Chen J, Li Z, Xu H, Zhang Z, Liu J, Wu J, et al. China national iodine deficiency disorders surveillance 1995. Beijing: People’s Medical Publishing House; 1997. p. 16–7.Google Scholar
  28. Chen X, Sun D, Liu S, Shen H, Xu H, Li Z, et al. China national iodine deficiency disorders surveillance 2002. Beijing: People’s Medical Publishing House; 2003. p. 55–7.Google Scholar
  29. Xiao D, Sun D, Bai H, Liu S, Shen H, Liu J, et al. China national iodine deficiency disorders surveillance 2005. Beijing: People’s Medical Publishing House; 2007. p. 43–6.Google Scholar
  30. Lu YL, Wang NJ, Zhu L, Wang GX, Wu H, Kuang L, et al. Investigation of iodine concentration in salt, water and soil along the coast of Zhejiang, China. J Zhejiang Univ Sci B. 2005;6(12):1200–5.View ArticlePubMedPubMed CentralGoogle Scholar
  31. World Health Organization. Vitamin and mineral requirements in human nutrition. Geneva: World Health Organization; 2004. p. 303–17.Google Scholar
  32. Chiesa A, Prieto L, Mendez V, Papendieck P, Calcagno ML, Gruneiro-Papendieck L. Prevalence and etiology of congenital hypothyroidism detected through an argentine neonatal screening program (1997-2010). Horm Res Paediatr. 2013;80(3):185–92.View ArticlePubMedGoogle Scholar
  33. Khajedaluee M, Rajabian R, Seyyednozadi M. Education achievements and goiter size ten years after iodized salt consuming. Int J Prev Med. 2013;4(8):876–80.PubMedPubMed CentralGoogle Scholar
  34. Yu J, Liu P, Liu Y, Liu SJ, Sun DJ. Should both iodised and non-iodised salt be made available in Chinese cities? A cross-sectional survey. BMJ Open. 2014;4(7):e005397.View ArticlePubMedPubMed CentralGoogle Scholar
  35. World Health Organization, International Classification for Patient Safety. Iodine and inorganic iodides: Human health aspects. Concise International Chemical Assessment Document 72. Geneva: World Health Organization; 2009. p. 5–31.Google Scholar
  36. Edmonds JC, McLean RM, Williams SM, Skeaff SA. Urinary iodine concentration of New Zealand adults improves with mandatory fortification of bread with iodised salt but not to predicted levels. Eur J Nutr. 2015;55(3):1201–12.View ArticlePubMedGoogle Scholar
  37. Manz F, Böhmer T, Gärtner R, Grossklaus R, Klett M, Schneider R. Quantification of iodine supply: representative data on intake and urinary excretion of iodine from the German population in 1996. Ann Nutr Metab. 2002;46(3-4):128–38.View ArticlePubMedGoogle Scholar
  38. Soldin OP. Controversies in urinary iodine determinations. Clin Biochem. 2002;35(8):575–9.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Zou S, Wu F, Guo C, Song J, Huang C, Zhu Z, et al. Iodine nutrition and the prevalence of thyroid disease after salt iodization: a cross-sectional survey in Shanghai, a coastal area in China. PLoS One. 2012;7(7):e40718.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Sun X, Shan Z, Teng W. Effects of increased iodine intake on thyroid disorders. Endocrinol Metab (Seoul). 2014;29(3):240–7.View ArticleGoogle Scholar
  41. Zhao H, Tian Y, Liu Z, Li X, Feng M, Huang T. Correlation between iodine intake and thyroid disorders: a cross-sectional study from the South of China. Biol Trace Elem Res. 2014;162(1-3):87–94.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement